Correlation Between Inhibrx and Hookipa Pharma
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Hookipa Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Hookipa Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Hookipa Pharma, you can compare the effects of market volatilities on Inhibrx and Hookipa Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Hookipa Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Hookipa Pharma.
Diversification Opportunities for Inhibrx and Hookipa Pharma
0.34 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Inhibrx and Hookipa is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Hookipa Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hookipa Pharma and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Hookipa Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hookipa Pharma has no effect on the direction of Inhibrx i.e., Inhibrx and Hookipa Pharma go up and down completely randomly.
Pair Corralation between Inhibrx and Hookipa Pharma
Given the investment horizon of 90 days Inhibrx is expected to generate 0.66 times more return on investment than Hookipa Pharma. However, Inhibrx is 1.52 times less risky than Hookipa Pharma. It trades about -0.01 of its potential returns per unit of risk. Hookipa Pharma is currently generating about -0.36 per unit of risk. If you would invest 1,555 in Inhibrx on September 3, 2024 and sell it today you would lose (29.00) from holding Inhibrx or give up 1.86% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibrx vs. Hookipa Pharma
Performance |
| Timeline |
| Inhibrx |
| Hookipa Pharma |
Inhibrx and Hookipa Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Hookipa Pharma
The main advantage of trading using opposite Inhibrx and Hookipa Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Hookipa Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hookipa Pharma will offset losses from the drop in Hookipa Pharma's long position.| Inhibrx vs. DiaMedica Therapeutics | Inhibrx vs. Lyra Therapeutics | Inhibrx vs. Centessa Pharmaceuticals PLC |
| Hookipa Pharma vs. Mereo BioPharma Group | Hookipa Pharma vs. Terns Pharmaceuticals | Hookipa Pharma vs. PDS Biotechnology Corp | Hookipa Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |